| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | allyl-alcohol dehydrogenase activity | 1.34e-06 | 4 | 140 | 3 | GO:0047655 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.16e-04 | 14 | 140 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.16e-04 | 14 | 140 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NADP+) activity | 1.44e-04 | 15 | 140 | 3 | GO:0052650 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.90e-04 | 4 | 140 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.52e-04 | 20 | 140 | 3 | GO:0061665 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 4.81e-04 | 5 | 140 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 7.19e-04 | 6 | 140 | 2 | GO:0045550 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 8.72e-04 | 27 | 140 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | endopeptidase activity | NAPSA ERVK-21 PRSS23 MEP1A ADAMTS12 CNTNAP5 TLL2 GZMM ADAMTS16 MMP11 | 9.22e-04 | 430 | 140 | 10 | GO:0004175 |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 3.03e-06 | 5 | 140 | 3 | GO:0097116 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.50e-05 | 9 | 140 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.55e-05 | 10 | 140 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | postsynaptic density protein 95 clustering | 4.85e-05 | 11 | 140 | 3 | GO:0097119 | |
| GeneOntologyBiologicalProcess | postsynaptic membrane assembly | 4.85e-05 | 11 | 140 | 3 | GO:0097104 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 8.33e-05 | 13 | 140 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.05e-04 | 14 | 140 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | PDE4D ANK3 ADGRV1 CD83 RUNX1 DCC PTK7 TENM4 HMCN2 NRXN1 NRXN2 SYK NECTIN4 COL14A1 NLGN2 MAPK7 PARD3 SDK1 GP1BA | 1.25e-04 | 1077 | 140 | 19 | GO:0098609 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.61e-05 | 8 | 140 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.41e-05 | 10 | 140 | 3 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.01e-04 | 14 | 140 | 3 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 2.23e-04 | 18 | 140 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | USH2 complex | 2.65e-04 | 4 | 140 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.08e-04 | 20 | 140 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.58e-04 | 21 | 140 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 6.56e-04 | 6 | 140 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 6.56e-04 | 6 | 140 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 6.56e-04 | 6 | 140 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 6.56e-04 | 6 | 140 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.15e-03 | 31 | 140 | 3 | GO:0060077 | |
| GeneOntologyCellularComponent | B cell receptor complex | 1.21e-03 | 8 | 140 | 2 | GO:0019815 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 1.21e-03 | 8 | 140 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | extracellular matrix | RUNX1 BGN ADAMTS12 LRRN3 HMCN2 ADAMTS16 NID1 COL14A1 MMP11 PZP USH2A GP1BA | 1.56e-03 | 656 | 140 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | RUNX1 BGN ADAMTS12 LRRN3 HMCN2 ADAMTS16 NID1 COL14A1 MMP11 PZP USH2A GP1BA | 1.60e-03 | 658 | 140 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.87e-03 | 78 | 140 | 4 | GO:0048787 | |
| MousePheno | failure of blastocyst formation | 4.74e-06 | 31 | 114 | 5 | MP:0012129 | |
| MousePheno | abnormal blastocyst formation | 1.52e-05 | 39 | 114 | 5 | MP:0012128 | |
| Domain | Rab_bind | 1.24e-05 | 7 | 134 | 3 | PF16704 | |
| Domain | GCC2_Rab_bind | 1.24e-05 | 7 | 134 | 3 | IPR032023 | |
| Domain | EGF_1 | 1.56e-05 | 255 | 134 | 10 | PS00022 | |
| Domain | ALDOKETO_REDUCTASE_1 | 4.18e-05 | 10 | 134 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 4.18e-05 | 10 | 134 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 4.18e-05 | 10 | 134 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 4.18e-05 | 10 | 134 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 4.18e-05 | 10 | 134 | 3 | IPR020471 | |
| Domain | - | 4.18e-05 | 10 | 134 | 3 | 1.10.220.60 | |
| Domain | Ig-like_fold | LRIT2 SEMA4B VSIG2 CD83 DCC PTK7 LRRN3 HMCN2 IGHE NECTIN4 COL14A1 HCFC2 USH2A SDK1 PLXNB1 LILRA4 | 4.70e-05 | 706 | 134 | 16 | IPR013783 |
| Domain | IGc2 | 5.06e-05 | 235 | 134 | 9 | SM00408 | |
| Domain | EGF_3 | 5.06e-05 | 235 | 134 | 9 | PS50026 | |
| Domain | Ig_sub2 | 5.06e-05 | 235 | 134 | 9 | IPR003598 | |
| Domain | Grip | 5.71e-05 | 11 | 134 | 3 | SM00755 | |
| Domain | GRIP | 5.71e-05 | 11 | 134 | 3 | PF01465 | |
| Domain | Laminin_G | 5.96e-05 | 58 | 134 | 5 | IPR001791 | |
| Domain | ZINC_PROTEASE | 7.47e-05 | 98 | 134 | 6 | PS00142 | |
| Domain | Ran_BP1 | 7.58e-05 | 12 | 134 | 3 | PF00638 | |
| Domain | RANBD1 | 7.58e-05 | 12 | 134 | 3 | PS50196 | |
| Domain | GRIP_dom | 7.58e-05 | 12 | 134 | 3 | IPR000237 | |
| Domain | GRIP | 7.58e-05 | 12 | 134 | 3 | PS50913 | |
| Domain | EGF-like_dom | 7.90e-05 | 249 | 134 | 9 | IPR000742 | |
| Domain | RanBD | 9.80e-05 | 13 | 134 | 3 | SM00160 | |
| Domain | Ran_bind_dom | 9.80e-05 | 13 | 134 | 3 | IPR000156 | |
| Domain | EGF_2 | 1.27e-04 | 265 | 134 | 9 | PS01186 | |
| Domain | Runt | 1.53e-04 | 3 | 134 | 2 | PF00853 | |
| Domain | RUNT | 1.53e-04 | 3 | 134 | 2 | PS51062 | |
| Domain | TF_Runt-rel_RUNX | 1.53e-04 | 3 | 134 | 2 | IPR016554 | |
| Domain | RunxI | 1.53e-04 | 3 | 134 | 2 | PF08504 | |
| Domain | Runt_dom | 1.53e-04 | 3 | 134 | 2 | IPR013524 | |
| Domain | RunxI_C_dom | 1.53e-04 | 3 | 134 | 2 | IPR013711 | |
| Domain | Runx_central_dom | 1.53e-04 | 3 | 134 | 2 | IPR027384 | |
| Domain | - | 1.53e-04 | 3 | 134 | 2 | 4.10.770.10 | |
| Domain | AML1_Runt | 1.53e-04 | 3 | 134 | 2 | IPR000040 | |
| Domain | LAM_G_DOMAIN | 1.55e-04 | 38 | 134 | 4 | PS50025 | |
| Domain | ConA-like_dom | 1.85e-04 | 219 | 134 | 8 | IPR013320 | |
| Domain | - | 1.89e-04 | 16 | 134 | 3 | 3.20.20.100 | |
| Domain | Laminin_G_2 | 1.89e-04 | 40 | 134 | 4 | PF02210 | |
| Domain | NADP_OxRdtase_dom | 2.28e-04 | 17 | 134 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 2.28e-04 | 17 | 134 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 2.28e-04 | 17 | 134 | 3 | IPR001395 | |
| Domain | LamG | 2.75e-04 | 44 | 134 | 4 | SM00282 | |
| Domain | - | 2.92e-04 | 81 | 134 | 5 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 2.92e-04 | 81 | 134 | 5 | IPR024079 | |
| Domain | G2F | 3.04e-04 | 4 | 134 | 2 | PF07474 | |
| Domain | NIDOGEN_G2 | 3.04e-04 | 4 | 134 | 2 | PS50993 | |
| Domain | GFP | 3.04e-04 | 4 | 134 | 2 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 3.04e-04 | 4 | 134 | 2 | IPR006605 | |
| Domain | FN3 | 3.81e-04 | 185 | 134 | 7 | SM00060 | |
| Domain | Ig_I-set | 4.47e-04 | 190 | 134 | 7 | IPR013098 | |
| Domain | I-set | 4.47e-04 | 190 | 134 | 7 | PF07679 | |
| Domain | FN3 | 5.89e-04 | 199 | 134 | 7 | PS50853 | |
| Domain | EGF-like_CS | 5.98e-04 | 261 | 134 | 8 | IPR013032 | |
| Domain | - | 6.10e-04 | 95 | 134 | 5 | 2.60.120.200 | |
| Domain | p53/RUNT-type_TF_DNA-bd | 7.52e-04 | 6 | 134 | 2 | IPR012346 | |
| Domain | - | 7.52e-04 | 6 | 134 | 2 | 2.60.40.720 | |
| Domain | Peptidase_M12A | 7.52e-04 | 6 | 134 | 2 | IPR001506 | |
| Domain | Astacin | 7.52e-04 | 6 | 134 | 2 | PF01400 | |
| Domain | FN3_dom | 7.86e-04 | 209 | 134 | 7 | IPR003961 | |
| Domain | IG_LIKE | LRIT2 VSIG2 CD83 DCC PTK7 LRRN3 HMCN2 IGHE NECTIN4 SDK1 LILRA4 | 8.33e-04 | 491 | 134 | 11 | PS50835 |
| Domain | IG | 9.27e-04 | 421 | 134 | 10 | SM00409 | |
| Domain | Ig_sub | 9.27e-04 | 421 | 134 | 10 | IPR003599 | |
| Domain | - | LRIT2 VSIG2 CD83 DCC PTK7 LRRN3 NECTIN4 COL14A1 HCFC2 USH2A SDK1 PLXNB1 LILRA4 | 9.75e-04 | 663 | 134 | 13 | 2.60.40.10 |
| Domain | Ig-like_dom | LRIT2 VSIG2 CD83 DCC PTK7 LRRN3 HMCN2 IGHE NECTIN4 SDK1 LILRA4 | 1.01e-03 | 503 | 134 | 11 | IPR007110 |
| Domain | Syndecan | 1.05e-03 | 7 | 134 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.05e-03 | 7 | 134 | 2 | IPR027789 | |
| Domain | fn3 | 1.12e-03 | 162 | 134 | 6 | PF00041 | |
| Domain | Peptidase_Metallo | 1.15e-03 | 29 | 134 | 3 | IPR006026 | |
| Domain | ZnMc | 1.15e-03 | 29 | 134 | 3 | SM00235 | |
| Domain | EGF | 1.55e-03 | 235 | 134 | 7 | SM00181 | |
| Domain | EGF | 2.15e-03 | 126 | 134 | 5 | PF00008 | |
| Domain | VWFA | 2.88e-03 | 82 | 134 | 4 | PS50234 | |
| Domain | VWA | 3.14e-03 | 84 | 134 | 4 | SM00327 | |
| Domain | CYSTEINE_SWITCH | 3.15e-03 | 41 | 134 | 3 | PS00546 | |
| Domain | Pept_M10_metallopeptidase | 3.61e-03 | 43 | 134 | 3 | IPR001818 | |
| Domain | ATPase_dyneun-rel_AAA | 4.39e-03 | 14 | 134 | 2 | IPR011704 | |
| Domain | Neurexin-like | 4.39e-03 | 14 | 134 | 2 | IPR003585 | |
| Domain | 4.1m | 4.39e-03 | 14 | 134 | 2 | SM00294 | |
| Domain | AAA_5 | 4.39e-03 | 14 | 134 | 2 | PF07728 | |
| Domain | LRRNT | 5.44e-03 | 98 | 134 | 4 | IPR000372 | |
| Domain | LRRNT | 5.44e-03 | 98 | 134 | 4 | SM00013 | |
| Domain | VWF_A | 5.64e-03 | 99 | 134 | 4 | IPR002035 | |
| Domain | p53-like_TF_DNA-bd | 6.51e-03 | 53 | 134 | 3 | IPR008967 | |
| Domain | LRRNT | 6.51e-03 | 53 | 134 | 3 | PF01462 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 7.16e-03 | 106 | 134 | 4 | IPR000152 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 9.45e-06 | 73 | 95 | 6 | MM14948 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 3.57e-05 | 92 | 95 | 6 | MM14951 | |
| Pubmed | Substrate specificity and catalytic efficiency of aldo-keto reductases with phospholipid aldehydes. | 6.66e-08 | 3 | 142 | 3 | 17381426 | |
| Pubmed | Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. | 6.66e-08 | 3 | 142 | 3 | 21424692 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.85e-07 | 13 | 142 | 4 | 31427429 | |
| Pubmed | TICRR CACNA2D1 VGLL3 PDE4D SCG5 ADGRV1 CD83 DCC MYO3A TENM4 STON2 SRL HEPHL1 PZP SDK1 PDZD2 | 2.45e-07 | 814 | 142 | 16 | 23251661 | |
| Pubmed | 3.68e-07 | 162 | 142 | 8 | 25826454 | ||
| Pubmed | 6.62e-07 | 5 | 142 | 3 | 10092857 | ||
| Pubmed | 1.32e-06 | 6 | 142 | 3 | 30683685 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.32e-06 | 6 | 142 | 3 | 8576240 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.30e-06 | 7 | 142 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.30e-06 | 7 | 142 | 3 | 11353387 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 30944974 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.30e-06 | 7 | 142 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.30e-06 | 7 | 142 | 3 | 17372272 | |
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 38657106 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 21205196 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 18949001 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 25187515 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 8603673 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 26632511 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 24403063 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 23818861 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 23536549 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 12191015 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 22821000 | ||
| Pubmed | 2.30e-06 | 7 | 142 | 3 | 20682751 | ||
| Pubmed | Calsyntenins function as synaptogenic adhesion molecules in concert with neurexins. | 2.35e-06 | 52 | 142 | 5 | 24613359 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 3.68e-06 | 8 | 142 | 3 | 21670213 | |
| Pubmed | 3.68e-06 | 8 | 142 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 3.68e-06 | 8 | 142 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 3.68e-06 | 8 | 142 | 3 | 22262462 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 3.68e-06 | 8 | 142 | 3 | 30871858 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 3.68e-06 | 8 | 142 | 3 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 5.50e-06 | 9 | 142 | 3 | 18394993 | |
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 34919427 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 28100513 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 17887960 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 11553612 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 10601307 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 9733766 | ||
| Pubmed | 5.50e-06 | 9 | 142 | 3 | 28877029 | ||
| Pubmed | 7.83e-06 | 10 | 142 | 3 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.83e-06 | 10 | 142 | 3 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.83e-06 | 10 | 142 | 3 | 8857542 | |
| Pubmed | 7.83e-06 | 10 | 142 | 3 | 21859863 | ||
| Pubmed | RGPD4 CACNA2D1 PDE4A ANK3 HECTD4 RGPD1 SYNPO NCOR2 CNTNAP5 NRXN1 RGPD3 STON2 NLGN2 PARD3 DYNC1H1 | 1.01e-05 | 963 | 142 | 15 | 28671696 | |
| Pubmed | 1.07e-05 | 11 | 142 | 3 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.07e-05 | 11 | 142 | 3 | 35771867 | |
| Pubmed | 1.07e-05 | 11 | 142 | 3 | 21642993 | ||
| Pubmed | 1.07e-05 | 11 | 142 | 3 | 34110283 | ||
| Pubmed | 1.07e-05 | 11 | 142 | 3 | 32973045 | ||
| Pubmed | Role of AKR1B10 and AKR1B8 in the pathogenesis of non-alcoholic steatohepatitis (NASH) in mouse. | 1.66e-05 | 2 | 142 | 2 | 34954342 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9233771 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15745835 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17560331 | ||
| Pubmed | Deletion of NRXN1α impairs long-range and local connectivity in amygdala fear circuit. | 1.66e-05 | 2 | 142 | 2 | 32684634 | |
| Pubmed | Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway. | 1.66e-05 | 2 | 142 | 2 | 25120755 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21087085 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 8526877 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 36518763 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30696833 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30709877 | ||
| Pubmed | Impaired Barrier Function and Immunity in the Colon of Aldo-Keto Reductase 1B8 Deficient Mice. | 1.66e-05 | 2 | 142 | 2 | 33644071 | |
| Pubmed | Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks. | 1.66e-05 | 2 | 142 | 2 | 33945128 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24880091 | ||
| Pubmed | Evaluation of compound selectivity of aldo-keto reductases using differential scanning fluorimetry. | 1.66e-05 | 2 | 142 | 2 | 28003428 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23146748 | ||
| Pubmed | Functional expression of novel human and murine AKR1B genes. | 1.66e-05 | 2 | 142 | 2 | 21276782 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 26595880 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 9520403 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 31911858 | ||
| Pubmed | Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis. | 1.66e-05 | 2 | 142 | 2 | 16059634 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 15671307 | ||
| Pubmed | Aldo-keto reductases-mediated cytotoxicity of 2-deoxyglucose: A novel anticancer mechanism. | 1.66e-05 | 2 | 142 | 2 | 29617059 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 34638692 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 32180230 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17290219 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 24100137 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 34445787 | ||
| Pubmed | Usher's Syndrome Type II: A Comparative Study of Genetic Mutations and Vestibular System Evaluation. | 1.66e-05 | 2 | 142 | 2 | 28653555 | |
| Pubmed | Opposing roles of the aldo-keto reductases AKR1B1 and AKR1B10 in colorectal cancer. | 1.66e-05 | 2 | 142 | 2 | 28929377 | |
| Pubmed | Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. | 1.66e-05 | 2 | 142 | 2 | 35551452 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 7578036 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23321257 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 8541228 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 32628753 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12732097 | ||
| Pubmed | Identification and characterization of a novel human aldose reductase-like gene. | 1.66e-05 | 2 | 142 | 2 | 9565553 | |
| Pubmed | Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. | 1.66e-05 | 2 | 142 | 2 | 1621094 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 17533052 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 25538260 | ||
| Pubmed | SIRT1 is a positive regulator of the master osteoblast transcription factor, RUNX2. | 1.66e-05 | 2 | 142 | 2 | 28542607 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 27634876 | ||
| Pubmed | AML1B transcriptional repressor function is impaired by the Flt3-internal tandem duplication. | 1.66e-05 | 2 | 142 | 2 | 16042694 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21329684 | ||
| Pubmed | Identification and expression of a novel 3'-exon of mouse Runx1/Pebp2alphaB/Cbfa2/AML1 gene. | 1.66e-05 | 2 | 142 | 2 | 10903914 | |
| Pubmed | A two-dimensional electrophoresis reference map of human ovary. | 1.85e-05 | 13 | 142 | 3 | 16021519 | |
| Pubmed | 2.40e-05 | 41 | 142 | 4 | 19343720 | ||
| Pubmed | 2.92e-05 | 15 | 142 | 3 | 28536193 | ||
| Interaction | NMS interactions | 1.62e-06 | 30 | 136 | 5 | int:NMS | |
| Cytoband | 19q13.33 | 2.08e-05 | 106 | 142 | 5 | 19q13.33 | |
| Cytoband | 15q25 | 2.63e-04 | 8 | 142 | 2 | 15q25 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.57e-05 | 161 | 90 | 7 | 593 | |
| GeneFamily | Aldo-keto reductases | 5.20e-05 | 15 | 90 | 3 | 399 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 1.46e-04 | 4 | 90 | 2 | 1244 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 3.63e-04 | 6 | 90 | 2 | 894 | |
| GeneFamily | Fibronectin type III domain containing | 1.22e-03 | 160 | 90 | 5 | 555 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.61e-03 | 115 | 90 | 4 | 769 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 3.97e-03 | 19 | 90 | 2 | 50 | |
| Coexpression | GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN | 1.36e-06 | 200 | 140 | 9 | M8543 | |
| Coexpression | GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN | 1.36e-06 | 200 | 140 | 9 | M8518 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 3.08e-06 | 221 | 140 | 9 | M39222 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.83e-05 | 33 | 140 | 4 | MM477 | |
| Coexpression | BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP | SCG5 PLEKHA4 MUC16 LNPEP UGDH NAV3 ZC3H12C HEPHL1 SDK1 PDZD2 | 3.76e-05 | 378 | 140 | 10 | M34022 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | GAD1 ANK3 PLEKHA6 DCC HIVEP3 LPIN1 NRXN1 NRXN2 ANKIB1 ZC3H12C USH2A | 4.24e-05 | 465 | 140 | 11 | M39066 |
| Coexpression | LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2 | 4.63e-05 | 176 | 140 | 7 | M39223 | |
| Coexpression | APPIERTO_RESPONSE_TO_FENRETINIDE_UP | 5.00e-05 | 38 | 140 | 4 | M1546 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 6.07e-05 | 126 | 140 | 6 | M39132 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | PDE4D ANK3 SCG5 PLEKHA6 REV3L DCC HIVEP3 LPIN1 NRXN1 NRXN2 NAV3 PRRT4 | 7.33e-05 | 584 | 140 | 12 | M39068 |
| Coexpression | GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP | 8.56e-05 | 194 | 140 | 7 | M6159 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | CACNA2D1 VGLL3 BGN ADAMTS12 TENM4 ADAMTS16 NAV3 COL14A1 PARD3 SDK1 | 7.73e-10 | 197 | 141 | 10 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-09 | 184 | 141 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-09 | 184 | 141 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-09 | 184 | 141 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.53e-08 | 199 | 141 | 9 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 1.60e-08 | 200 | 141 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.95e-08 | 169 | 141 | 8 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-08 | 174 | 141 | 8 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-08 | 176 | 141 | 8 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.50e-08 | 176 | 141 | 8 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-07 | 180 | 141 | 8 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-07 | 180 | 141 | 8 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-07 | 183 | 141 | 8 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-07 | 183 | 141 | 8 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-07 | 183 | 141 | 8 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.39e-07 | 185 | 141 | 8 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.51e-07 | 187 | 141 | 8 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-07 | 189 | 141 | 8 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 190 | 141 | 8 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-07 | 190 | 141 | 8 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-07 | 191 | 141 | 8 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-07 | 192 | 141 | 8 | 30cefa0990ba1f379f350bfbf994a78db145075e | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.85e-07 | 192 | 141 | 8 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 2.26e-07 | 197 | 141 | 8 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.26e-07 | 197 | 141 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.53e-07 | 200 | 141 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 2.53e-07 | 200 | 141 | 8 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 356C-Myeloid-Dendritic-pDC|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.05e-07 | 163 | 141 | 7 | ae9c5eb19657ea94b7f2357cbc8679acd697b8fe | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-06 | 170 | 141 | 7 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-06 | 176 | 141 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.69e-06 | 179 | 141 | 7 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.76e-06 | 180 | 141 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-06 | 183 | 141 | 7 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 2.03e-06 | 184 | 141 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 184 | 141 | 7 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.26e-06 | 187 | 141 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-25|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.26e-06 | 187 | 141 | 7 | 0d4b7da81036c2aa678654b9fe49c939d08fcd9b | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 2.26e-06 | 187 | 141 | 7 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.34e-06 | 188 | 141 | 7 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | (0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 2.34e-06 | 188 | 141 | 7 | a81b5d840490d6a636fe168f8cff2c4984369f09 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.34e-06 | 188 | 141 | 7 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 2.34e-06 | 188 | 141 | 7 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.43e-06 | 189 | 141 | 7 | dc5164591dea45b420798b94dda211be03daa70c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.51e-06 | 190 | 141 | 7 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.51e-06 | 190 | 141 | 7 | 3cf464664d6aa22b212e60b70885953887e92483 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Tem/emra_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.51e-06 | 190 | 141 | 7 | 66d29f53f129fc18771f6214316a913eeaccd55e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 141 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.60e-06 | 191 | 141 | 7 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 141 | 7 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.60e-06 | 191 | 141 | 7 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 141 | 7 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 141 | 7 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 141 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.60e-06 | 191 | 141 | 7 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 192 | 141 | 7 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.69e-06 | 192 | 141 | 7 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 192 | 141 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-06 | 192 | 141 | 7 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.69e-06 | 192 | 141 | 7 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.79e-06 | 193 | 141 | 7 | 3ea6b103e35bbb276e95301999618558fa3e38b1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-06 | 193 | 141 | 7 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | 21-Trachea-Epithelial-Epithelial|Trachea / Age, Tissue, Lineage and Cell class | 2.79e-06 | 193 | 141 | 7 | 9a8bb44a37f3202e3123a6680bd5545dc91a6d40 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.79e-06 | 193 | 141 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.79e-06 | 193 | 141 | 7 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.89e-06 | 194 | 141 | 7 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.89e-06 | 194 | 141 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 194 | 141 | 7 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.89e-06 | 194 | 141 | 7 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.89e-06 | 194 | 141 | 7 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 2.89e-06 | 194 | 141 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.89e-06 | 194 | 141 | 7 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 194 | 141 | 7 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.89e-06 | 194 | 141 | 7 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.99e-06 | 195 | 141 | 7 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.99e-06 | 195 | 141 | 7 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-06 | 195 | 141 | 7 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-06 | 196 | 141 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.09e-06 | 196 | 141 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.09e-06 | 196 | 141 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 196 | 141 | 7 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-06 | 196 | 141 | 7 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 197 | 141 | 7 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 197 | 141 | 7 | ae0435f4b4a9cdedb1c201fc56921048390097bf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-06 | 197 | 141 | 7 | 37f6b6f2809b952382eaebb642b0aad6371f4251 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.30e-06 | 198 | 141 | 7 | 9718f4c013c347f1b3c785ae232dd2fb6c1fe298 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-06 | 198 | 141 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 3.30e-06 | 198 | 141 | 7 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | cellseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Suprabasal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.30e-06 | 198 | 141 | 7 | 6e047de63ef59dcb47e4fc06b173b2a02fdcf4c9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-06 | 198 | 141 | 7 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.30e-06 | 198 | 141 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-06 | 199 | 141 | 7 | d04062d86643e5712cc2f519f4f36e643d404a16 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.41e-06 | 199 | 141 | 7 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.41e-06 | 199 | 141 | 7 | a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937 | |
| ToppCell | Severe_COVID-19-Epithelial-Basal/Club|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 3.41e-06 | 199 | 141 | 7 | 2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.41e-06 | 199 | 141 | 7 | fd364f43859b2e7a3e91ce6a1c430cc42ad26a49 | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.41e-06 | 199 | 141 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 3.41e-06 | 199 | 141 | 7 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Basal/Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.41e-06 | 199 | 141 | 7 | 644197ff7e3299587881dd678836262e670ed4a8 | |
| Drug | Rolitetracycline [751-97-3]; Up 200; 7.6uM; MCF7; HT_HG-U133A | GAD1 CACNA2D1 SLC6A16 GAS7 RUNX1 HIVEP3 MYOZ1 C6 PARD3 MMP11 LILRA4 | 3.23e-08 | 196 | 138 | 11 | 3369_UP |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; HL60; HT_HG-U133A | PDE4A RBPMS PDE4D ANK3 SLC6A16 TEX14 RUNX1 MYOZ1 COL14A1 PARD3 | 4.07e-07 | 200 | 138 | 10 | 2575_UP |
| Drug | Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.18e-06 | 196 | 138 | 9 | 4752_UP | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.75e-06 | 200 | 138 | 9 | 4088_DN | |
| Drug | NSC726617 | 7.14e-06 | 21 | 138 | 4 | CID011360432 | |
| Drug | alcophosphamide | 1.19e-05 | 8 | 138 | 3 | CID000098612 | |
| Drug | Cantharidin [56-25-7]; Up 200; 20.4uM; HL60; HT_HG-U133A | 1.57e-05 | 182 | 138 | 8 | 3075_UP | |
| Drug | olmesartan | 1.94e-05 | 91 | 138 | 6 | CID000158781 | |
| Drug | Glyceraldehyde | 2.53e-05 | 10 | 138 | 3 | ctd:D005985 | |
| Drug | Aceclofenac [89796-99-6]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 7269_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 4718_DN | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 4390_UP | |
| Drug | Ethamivan [304-84-7]; Up 200; 18uM; PC3; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 7260_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 6475_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; MCF7; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 4698_DN | |
| Drug | 4-oxoretinaldehyde | 3.65e-05 | 2 | 138 | 2 | ctd:C099660 | |
| Drug | propioin | 3.65e-05 | 2 | 138 | 2 | ctd:C523189 | |
| Drug | dehydroretinal | 3.65e-05 | 2 | 138 | 2 | ctd:C017184 | |
| Drug | Pentanones | 3.65e-05 | 2 | 138 | 2 | ctd:D010422 | |
| Drug | 4-hydroxyretinal | 3.65e-05 | 2 | 138 | 2 | ctd:C057180 | |
| Drug | (4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one | 3.65e-05 | 2 | 138 | 2 | DB06842 | |
| Disease | Autism Spectrum Disorders | 2.55e-06 | 85 | 134 | 6 | C1510586 | |
| Disease | balding measurement | BCL2L14 PDE4D VWA8 REV3L RUNX2 RUNX1 BGN NCOR2 PTPN14 EIF4E3 PARD3 AKR1B1 KIAA2012 HSPA4 | 1.57e-05 | 792 | 134 | 14 | EFO_0007825 |
| Disease | Schizophrenia | GAD1 PDE4A PDE4D ANK3 GABRQ PLEKHA6 DCC SIRT1 ADAMTS12 TENM4 NRXN1 NRXN2 STON2 NLGN2 | 5.14e-05 | 883 | 134 | 14 | C0036341 |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 7.35e-05 | 49 | 134 | 4 | DOID:0060037 (implicated_via_orthology) | |
| Disease | hearing impairment | 8.68e-05 | 98 | 134 | 5 | C1384666 | |
| Disease | aldose reductase measurement | 1.22e-04 | 4 | 134 | 2 | EFO_0801364 | |
| Disease | esophageal carcinoma | 3.40e-04 | 30 | 134 | 3 | EFO_0002916 | |
| Disease | Bipolar Disorder | 3.43e-04 | 477 | 134 | 9 | C0005586 | |
| Disease | pentachlorophenol measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022071 | |
| Disease | parathion measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022070 | |
| Disease | potassium chromate measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022072 | |
| Disease | mercuric chloride measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022068 | |
| Disease | heptachlor epoxide measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022067 | |
| Disease | methoxychlor measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022069 | |
| Disease | 4,6-dinitro-o-cresol measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022053 | |
| Disease | 2,4,5-trichlorophenol measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022052 | |
| Disease | azinphos methyl measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022055 | |
| Disease | aldrin measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022054 | |
| Disease | dicofol measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022060 | |
| Disease | disulfoton measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022062 | |
| Disease | dieldrin measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022061 | |
| Disease | endrin measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022064 | |
| Disease | endosulfan measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022063 | |
| Disease | heptachlor measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022066 | |
| Disease | ethion measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022065 | |
| Disease | chlorpyrifos measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022057 | |
| Disease | cadmium chloride measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022056 | |
| Disease | diazinon measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022059 | |
| Disease | dibutyl phthalate measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0022058 | |
| Disease | environmental exposure measurement | 3.47e-04 | 73 | 134 | 4 | EFO_0008360 | |
| Disease | DDT metabolite measurement | 3.66e-04 | 74 | 134 | 4 | EFO_0007886 | |
| Disease | Manic | 4.47e-04 | 78 | 134 | 4 | C0338831 | |
| Disease | hypertension | 5.25e-04 | 307 | 134 | 7 | EFO_0000537 | |
| Disease | NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO | 5.63e-04 | 8 | 134 | 2 | C3891448 | |
| Disease | biological sex | 6.58e-04 | 230 | 134 | 6 | PATO_0000047 | |
| Disease | symmetrical dimethylarginine measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0006523 | |
| Disease | white matter growth measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0009335 | |
| Disease | risk-taking behaviour | VGLL3 REV3L DCC FIGN HIVEP3 CNTNAP5 TENM4 NRXN1 KIAA2012 TET3 SDK1 | 7.51e-04 | 764 | 134 | 11 | EFO_0008579 |
| Disease | smoking status measurement | POLR1A NOL6 HECTD4 REV3L DCC FIGN TENM4 NRXN1 NRXN2 LNPEP SETD3 USH2A TET3 SDK1 | 8.30e-04 | 1160 | 134 | 14 | EFO_0006527 |
| Disease | hip geometry | 1.06e-03 | 44 | 134 | 3 | EFO_0004685 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | NOL6 REV3L DCC FIGN CNTNAP5 TENM4 NRXN1 NRXN2 USH2A TET3 SDK1 | 1.10e-03 | 801 | 134 | 11 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.13e-03 | 45 | 134 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | middle cerebral artery infarction (implicated_via_orthology) | 1.13e-03 | 45 | 134 | 3 | DOID:3525 (implicated_via_orthology) | |
| Disease | blood cobalt measurement | 1.18e-03 | 101 | 134 | 4 | EFO_0007577 | |
| Disease | Rheumatoid Arthritis | 1.22e-03 | 174 | 134 | 5 | C0003873 | |
| Disease | waist-hip ratio | NUDT18 VGLL3 ANK3 HECTD4 RUNX1 FIGN RFX4 PTK7 MEP1A NAV3 TBX10 NID1 COL14A1 HSPA4 | 1.40e-03 | 1226 | 134 | 14 | EFO_0004343 |
| Disease | Colorectal Carcinoma | 1.41e-03 | 702 | 134 | 10 | C0009402 | |
| Disease | esophageal squamous cell carcinoma | 1.55e-03 | 13 | 134 | 2 | EFO_0005922 | |
| Disease | lower face morphology measurement | 1.57e-03 | 109 | 134 | 4 | EFO_0010948 | |
| Disease | hair colour measurement | 2.04e-03 | 615 | 134 | 9 | EFO_0007822 | |
| Disease | blood nickel measurement | 2.22e-03 | 120 | 134 | 4 | EFO_0007583 | |
| Disease | response to antipsychotic drug | 2.59e-03 | 60 | 134 | 3 | GO_0097332 | |
| Disease | melanoma | 2.65e-03 | 126 | 134 | 4 | EFO_0000756 | |
| Disease | sphingomyelin 14:0 measurement | 2.66e-03 | 17 | 134 | 2 | EFO_0010390 | |
| Disease | skin sensitivity to sun | 3.33e-03 | 19 | 134 | 2 | EFO_0004795 | |
| Disease | cystathionine measurement | 3.33e-03 | 19 | 134 | 2 | EFO_0010474 | |
| Disease | skin pigmentation measurement | 3.58e-03 | 137 | 134 | 4 | EFO_0007009 | |
| Disease | chronic kidney disease (is_marker_for) | 3.69e-03 | 20 | 134 | 2 | DOID:784 (is_marker_for) | |
| Disease | alpha-tocopherol measurement | 3.69e-03 | 20 | 134 | 2 | EFO_0007898 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.70e-03 | 68 | 134 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | heart rate | 3.71e-03 | 225 | 134 | 5 | EFO_0004326 | |
| Disease | brain measurement, neuroimaging measurement | 3.72e-03 | 550 | 134 | 8 | EFO_0004346, EFO_0004464 | |
| Disease | Manic Disorder | 4.18e-03 | 71 | 134 | 3 | C0024713 | |
| Disease | Intellectual Disability | 4.42e-03 | 447 | 134 | 7 | C3714756 | |
| Disease | hemoglobin change measurement | 4.46e-03 | 22 | 134 | 2 | EFO_0600027 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGNSPTPVSRWIYPQ | 176 | O95429 | |
| PPVATAVAPYVSWIR | 236 | P51124 | |
| YESPIQGVPDPLWRT | 2411 | Q8WXG9 | |
| SLTPPPQNTITWEEY | 411 | Q8N6S4 | |
| RVAEIVYSWPPPQAT | 156 | Q9BZR8 | |
| TVTAYSPLGSPDRPW | 206 | O60218 | |
| YNAWDTLPSPRTPRT | 296 | Q9P2G1 | |
| WTPAFAYSPRTPDRV | 21 | P05408 | |
| AYIWKVSTPWQPPTV | 341 | Q9NZJ0 | |
| SSRNPITWPVTPFYN | 1131 | P58397 | |
| PPAQPSYTWAIVRSE | 866 | Q8TE57 | |
| VVTAYSPLGSPDRPW | 206 | P15121 | |
| TVPALYPSSPEVWAP | 136 | Q93062 | |
| GPVPETVRSYFPETW | 731 | P20742 | |
| GSPQRSPWVFVPYQS | 361 | Q7Z3H0 | |
| VVAPNSPIWYSVQPI | 731 | Q2TAL8 | |
| VTPRWPEVPSANTCY | 671 | Q33E94 | |
| TYPSAPRHTIAPRNW | 116 | A8MYP8 | |
| TAPWDPQVPYTVSWV | 36 | Q01151 | |
| PVPWETVYPGADRQA | 306 | Q13164 | |
| SPSWKSSPYERIAPS | 3921 | Q8WXI7 | |
| SPDWPPASQYTEIPV | 10211 | Q8WXI7 | |
| QPVAQTWRATEPRYP | 6 | Q9Y618 | |
| LWTDSPEPSFNPYSR | 356 | Q504Q3 | |
| PTSILITWEPPAYAN | 541 | P43146 | |
| SEPWQPSLNSEAVYP | 106 | Q5HY92 | |
| TYKWPPNDRPSTRAD | 101 | P58400 | |
| NTPYVWSEPSDPLQL | 201 | P59901 | |
| SWEPPTSPSGNILEY | 696 | Q9Y5Z7 | |
| PRNPKTPTERIYWAN | 286 | Q3ZCV2 | |
| DVVPYPISLRWNSPA | 396 | P34932 | |
| QAAWYPRTSLPTPLR | 141 | Q6ZVK8 | |
| AQASPSPSIAWTYPL | 276 | A6NDA9 | |
| ARWVAPSYRTEPVPG | 101 | Q5JR98 | |
| PSYRTEPVPGERWEA | 106 | Q5JR98 | |
| STVSFNPYEPELAPW | 316 | P43405 | |
| IRTWLAEGNYPSPIP | 16 | Q9UN88 | |
| WTKDSRPVPPITNRY | 1106 | Q8NDA2 | |
| DTNAIPPPDLTWYRE | 2781 | Q8NDA2 | |
| WYIPQSLRGVPDSPQ | 516 | Q99259 | |
| RSDVPYPLLSSPVQW | 11 | B1ANH7 | |
| TRALWPPDPQAAFSY | 186 | O43157 | |
| APAYPQWASQPSVLD | 1491 | O15018 | |
| RDWYYSAIRQSPSPP | 676 | P27815 | |
| EWYQSTIPQSPSPAP | 706 | Q08499 | |
| PVPYWEVQPATFRCV | 341 | P21810 | |
| TWESVAPYQGPSRDP | 156 | P14543 | |
| TYPWSSATLPQESPA | 2296 | Q8IVL0 | |
| QWPPIYTAAREQTPF | 86 | P35663 | |
| ALITYTWPPNDRPST | 1146 | Q9P2S2 | |
| EPPTPRYNTWVLQDT | 291 | Q9H6R4 | |
| LNWRSPEDYVPVSKP | 31 | Q0VF49 | |
| SASYPNSDREWSPTP | 226 | Q14693 | |
| PEIQPSDTSYLWHIP | 641 | Q9UIQ6 | |
| YPAPTSDLWPQVTRL | 126 | Q6IPT2 | |
| TYKWPPNDRPSTRAD | 1136 | Q9ULB1 | |
| ITYDDPIKTSWTPPR | 136 | Q9UJV9 | |
| VELPPWSYSVPSLNS | 1446 | Q9Y4D8 | |
| WSVYNNIPPVTSLPL | 86 | Q8N5X7 | |
| SVPPRPWSYPRQAES | 131 | Q8TB68 | |
| APYIPSTDPQDWLTQ | 216 | Q13772 | |
| LITYTWPPNDRPSTR | 101 | P58401 | |
| YSPKTPPRWAEDQNS | 796 | A6NKT7 | |
| TTPSTSLYATNPPWI | 21 | Q5T0Z8 | |
| SPSPQPPYVRLWEEA | 91 | Q8WZ55 | |
| PSRYTCQGNSWTPPI | 741 | P13671 | |
| RYYPASPWVDNSRTP | 216 | P54289 | |
| EPYATTSQLRPRPNW | 91 | Q96ST8 | |
| WYNRLRITWDPPSSP | 841 | Q05707 | |
| PIVPAQYQAPSTRWG | 121 | A6NCJ1 | |
| VHPYIPQVDSWTDPN | 71 | P28358 | |
| RPYQSWTTAPITVPG | 1501 | Q12955 | |
| TNWAYVPFPPLIRAV | 101 | P61565 | |
| EQTTFPPRWTPNFTL | 351 | P07359 | |
| WPVREEYAPTPADAN | 166 | Q6MZM0 | |
| RAAPEVYAFATPEWP | 321 | P01854 | |
| STVWGQPDIRLPPTY | 66 | A6NK06 | |
| PEQTVPYLWSEETPA | 3966 | Q14204 | |
| PYLWSEETPATPIGQ | 3971 | Q14204 | |
| AYFPEERWSPESPLQ | 36 | Q8NBJ5 | |
| NLLPITSYPRPQVTW | 211 | Q7Z5N4 | |
| VYTSERWDQPPHPQI | 111 | Q16617 | |
| FTTTTRLPPYATRWP | 616 | Q8NFZ4 | |
| APPAPDSTWVQIYSG | 471 | Q8WYK1 | |
| PWLVGSLPPQTARDY | 206 | Q9BT04 | |
| YRPPDRSAPSWNTTV | 1231 | Q9HC10 | |
| TYSFEQPWPNARPAT | 1176 | Q8TEW0 | |
| YSPKTPPRWAEDQNS | 786 | P0DJD0 | |
| YGLIWVPTRSPAAPA | 51 | C9JVW0 | |
| PIQPFYSSPELWISS | 206 | O14896 | |
| LYGQPWPTVTSRTPA | 256 | P24347 | |
| QDTRQIQPSPPWSYD | 241 | Q01196 | |
| TDPRQAQSSPPWSYD | 286 | Q13950 | |
| AVDQDWPSVYPVAAP | 61 | P82673 | |
| SSYIRWPVPIVPVLA | 51 | Q5HYW3 | |
| PLSESYVVISWQPPS | 2831 | O75445 | |
| YSPKTPPRWAEDQNS | 796 | Q7Z3J3 | |
| VFATKLTYPQPVTPW | 461 | O95602 | |
| STSKEVLRPYPPWAL | 646 | Q9GZN6 | |
| TRVPLPTQLYNWAAP | 411 | Q8IWB6 | |
| YIWRLSKRQPPDTTP | 806 | Q969F9 | |
| ATAEPQPEIYWITPS | 446 | Q9H3W5 | |
| GSWSSPRNTTPYLPT | 651 | Q9H4M7 | |
| TAPLASWVRSPPSYS | 571 | Q8N3V7 | |
| TVILPPGWQSYLSPQ | 76 | O60861 | |
| TWPAYRLPVVLPQST | 31 | O95084 | |
| PNTRWTFPIPYILAD | 71 | Q16819 | |
| QPTWSRSSLPRQQPY | 321 | Q15678 | |
| TQQWYTVTHPVPTPR | 381 | Q9NPR2 | |
| ASPNSFWQPYIQTLP | 166 | Q86TU7 | |
| ASSSDWTPRPRIGPY | 171 | Q96EB6 | |
| WTPRPRIGPYTFVQQ | 176 | Q96EB6 | |
| LLWPSSVPAYPSITV | 11 | Q6UW49 | |
| DWTVAPPVPATPYEA | 46 | Q01892 | |
| APPVTSARFPSWVTF | 221 | Q8WXE9 | |
| TVTAYSPLGSPDRPW | 206 | C9JRZ8 | |
| FPARQAWYRPASPES | 321 | Q8NCH0 | |
| ETYPLPTTSSGWEPR | 16 | O75333 | |
| PPQGNSSIRYPFESW | 151 | Q9NYW4 | |
| RINAWNSPTLPIYEP | 41 | O60701 | |
| TVWIPSPSRQPVYYD | 421 | Q9Y2H5 | |
| SIYPPIPGEESSLRW | 61 | P82912 | |
| TDVLYVPGPLSPWAQ | 201 | A0A0J9YY54 | |
| YQWDRPEITSPTKPI | 111 | Q7Z2Z1 | |
| SYSSPDSPVIPPWQQ | 2116 | O60673 | |
| TETPGTAYPASPREW | 51 | P60508 | |
| LYNWTPPSTPSFRER | 341 | Q96MK2 | |
| ECSPWPEITYVNNSP | 276 | Q12800 | |
| LIEISWTETYPQTPP | 46 | Q6NW29 | |
| NVTEPPRVYVSSFWP | 281 | Q86TD4 | |
| SALSYKPVSPRRPWS | 1956 | Q5T1R4 | |
| YSPTRRWSPGQAESP | 2066 | Q5T1R4 | |
| TLASPNWPDKYPSRR | 786 | Q9Y6L7 | |
| GPTAPYQPRRSTVTW | 141 | C9JH25 | |
| TASSWPVPTDVSLYP | 386 | Q6N022 | |
| PPVSYNDTAPRILFW | 256 | Q15904 | |
| SPQSYLRAPSWPVVP | 396 | O43151 | |
| WRYAVQLPTPQPVAD | 226 | Q9Y2I8 | |
| ARIYPFWTPDIPLSS | 166 | Q5R3I4 | |
| YVESTDPQLSPAVPW | 46 | Q9C0D7 | |
| PAVSESWPYPLTSQV | 201 | A8MV65 | |
| PPVLSSRPGIADTWY | 486 | Q1EHB4 | |
| IPIPRSESLSPYTTW | 1466 | A3KMH1 | |
| VYNWVRLGTFPTPSP | 176 | Q96IQ7 | |
| PRPTYQWFRDGTPLS | 156 | Q13308 | |
| AREIPPQPWYKSTVI | 451 | O15321 | |
| CNITESYPAVPPIWS | 106 | Q7Z7E8 | |
| NRKVTNTTPWEHPYP | 176 | Q309B1 | |
| YAWDEPTLPPFITLT | 3551 | Q5THJ4 | |
| KAISERPSYPVPWLA | 1261 | Q8NEV4 | |
| RPSYPVPWLAENETS | 1266 | Q8NEV4 | |
| TPIPWLSSGEPVDYN | 271 | Q9NP98 | |
| PLTFVPVTVPAYWQI | 246 | O96009 | |
| LSEGQPPPSYNWTRL | 271 | Q96NY8 |